Brief: Nektar Therapeutics Announces Pricing Of $100 Million Public Offering
July 1 (Reuters) - Nektar Therapeutics NKTR.O: NEKTAR THERAPEUTICS ANNOUNCES PRICING OF $100 MILLION PUBLIC OFFERING NEKTAR THERAPEUTICS - SELLING 4,255,320 SHARES AT $23.50 PER SHARE Source text: ID:nPn6KFt5a Further company coverage: NKTR.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Nektar Therapeutics
See all newsBrief: Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Nektar Therapeutics Rezpegaldesleukin Demonstrates Durability And Deepening Of Response Through One Year Of Treatment
U.S. STOCKS ON THE MOVEx-Microsoft, 3M, Twilio
U.S. STOCKS ON THE MOVEx-Microsoft, Nike, Nektar Therapeutics
Eli Lilly owes Nektar $90 mln in drug collaboration dispute, US jury says